142 related articles for article (PubMed ID: 23524243)
1. Regulation of mevalonate metabolism in cancer and immune cells.
Thurnher M; Gruenbacher G; Nussbaumer O
Biochim Biophys Acta; 2013 Jun; 1831(6):1009-15. PubMed ID: 23524243
[TBL] [Abstract][Full Text] [Related]
2. Novel aspects of mevalonate pathway inhibitors as antitumor agents.
Thurnher M; Nussbaumer O; Gruenbacher G
Clin Cancer Res; 2012 Jul; 18(13):3524-31. PubMed ID: 22529099
[TBL] [Abstract][Full Text] [Related]
3. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1995 Apr; 55(8):1732-40. PubMed ID: 7712482
[TBL] [Abstract][Full Text] [Related]
5. High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.
Mather A; Chen XM; McGinn S; Field MJ; Sumual S; Mangiafico S; Zhang Y; Kelly DJ; Pollock CA
Int J Biochem Cell Biol; 2009 Mar; 41(3):561-9. PubMed ID: 18692592
[TBL] [Abstract][Full Text] [Related]
6. Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis.
Healey GD; Collier C; Griffin S; Schuberth HJ; Sandra O; Smith DG; Mahan S; Dieuzy-Labaye I; Sheldon IM
J Immunol; 2016 Jan; 196(2):823-31. PubMed ID: 26673142
[TBL] [Abstract][Full Text] [Related]
7. Mevalonate metabolism in cancer.
Gruenbacher G; Thurnher M
Cancer Lett; 2015 Jan; 356(2 Pt A):192-6. PubMed ID: 24467965
[TBL] [Abstract][Full Text] [Related]
8. Differential prenylation of proteins as a function of mevalonate concentration in CHO cells.
Rilling HC; Bruenger E; Leining LM; Buss JE; Epstein WW
Arch Biochem Biophys; 1993 Mar; 301(2):210-5. PubMed ID: 8460935
[TBL] [Abstract][Full Text] [Related]
9. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Henneman L; van Cruchten AG; Kulik W; Waterham HR
Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
[TBL] [Abstract][Full Text] [Related]
11. The analytical determination of isoprenoid intermediates from the mevalonate pathway.
Nürenberg G; Volmer DA
Anal Bioanal Chem; 2012 Jan; 402(2):671-85. PubMed ID: 21789486
[TBL] [Abstract][Full Text] [Related]
12. T lymphocyte regulation by mevalonate metabolism.
Thurnher M; Gruenbacher G
Sci Signal; 2015 Mar; 8(370):re4. PubMed ID: 25829448
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the mevalonate pathway ameliorates anoxia-induced down-regulation of FKBP12.6 and intracellular calcium handling dysfunction in H9c2 cells.
Yang Y; Lu X; Rong X; Jiang W; Lai D; Ma Y; Zhou K; Fu G; Xu S
J Mol Cell Cardiol; 2015 Mar; 80():166-74. PubMed ID: 25636197
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol and beyond - The role of the mevalonate pathway in cancer biology.
Göbel A; Rauner M; Hofbauer LC; Rachner TD
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188351. PubMed ID: 32007596
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Small GTPase Prenylation in the Nervous System.
Reddy JM; Raut NGR; Seifert JL; Hynds DL
Mol Neurobiol; 2020 May; 57(5):2220-2231. PubMed ID: 31989383
[TBL] [Abstract][Full Text] [Related]
16. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Induction of Trained Immunity through the Mevalonate Pathway.
Bekkering S; Arts RJW; Novakovic B; Kourtzelis I; van der Heijden CDCC; Li Y; Popa CD; Ter Horst R; van Tuijl J; Netea-Maier RT; van de Veerdonk FL; Chavakis T; Joosten LAB; van der Meer JWM; Stunnenberg H; Riksen NP; Netea MG
Cell; 2018 Jan; 172(1-2):135-146.e9. PubMed ID: 29328908
[TBL] [Abstract][Full Text] [Related]
18. Cardiac decompensation and promiscuous prenylation of small GTPases in cardiomyocytes in response to local mevalonate pathway disruption.
Essandoh K; Auchus RJ; Brody MJ
J Pathol; 2022 Mar; 256(3):249-252. PubMed ID: 34783037
[TBL] [Abstract][Full Text] [Related]
19. The interplay between cell signalling and the mevalonate pathway in cancer.
Mullen PJ; Yu R; Longo J; Archer MC; Penn LZ
Nat Rev Cancer; 2016 Nov; 16(11):718-731. PubMed ID: 27562463
[TBL] [Abstract][Full Text] [Related]
20. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
